| Literature DB >> 30567492 |
Rezvan Ehsani1,2, Finn Drabløs3.
Abstract
BACKGROUND: Almost 16,000 human long non-coding RNA (lncRNA) genes have been identified in the GENCODE project. However, the function of most of them remains to be discovered. The function of lncRNAs and other novel genes can be predicted by identifying significantly enriched annotation terms in already annotated genes that are co-expressed with the lncRNAs. However, such approaches are sensitive to the methods that are used to estimate the level of co-expression.Entities:
Keywords: Co-expression; Fisher information metric; Function prediction; Gene annotation; Sobolev metric, semantic similarity
Mesh:
Substances:
Year: 2018 PMID: 30567492 PMCID: PMC6300029 DOI: 10.1186/s12859-018-2546-y
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.169
Fig. 1The “guilt by association” principle for prediction of annotation terms for a novel gene. It is based on comparison of gene expression profiles between the novel gene and a set of annotated genes, ranking of the annotated genes according to the similarity of the expression profiles relative to the novel gene, and enrichment analysis of annotation terms in the most highly ranked annotated genes. The significantly enriched terms can be used as an estimate of annotation for the novel gene
Pseudocode of the LNCRNA2GOA algorithm
Fig. 2Evaluation of the different similarity metrics for 352 well-annotated protein-coding genes (Test352). For each gene in Test352 all methods were applied for prediction of function, and similarity between real and predicted terms were measured with TopoICSim and GOSemSim. The table shows average similarity scores over the test set, with standard deviation. LncRNA2Function: Co-expressed protein-coding genes was obtained for each gene in Test352 using [22] with Pearson correlation coefficient > 0.9. Co-LncRNA_Pearson or _Spearman: Co-expressed protein-coding genes was obtained for each gene in Test352 using [24] with Pearson or Spearman correlation coefficient > 0.8 and LncRNA2Function expression data
Fig. 3GO terms for a manually annotated set of 37 lncRNAs from FuncPred has been predicted using LNCRNA2GOA, FuncPred and LncRNA2Function, and the number of successful predictions has been counted
Summary information describing the five case studies for human lncRNAs
| Ensembl ID | Gene symbol | Name | Selected references |
|---|---|---|---|
| ENSG00000228630 | HOTAIR | Hox transcript antisense RNA | [ |
| ENSG00000206337 | HCP5 | HLA complex P5 | [ |
| ENSG00000251164 | HULC | Heptacellular carcinoma up-regulated long non-coding RNA | [ |
| ENSG00000130600 | H19 | Imprinted maternally expressed transcript | [ |
| ENSG00000225937 | PCA3 | Prostate cancer associated 3 | [ |
Top 10 biological processes assigned to each of the selected case studies
| GO ID | FDR | Term | |
|---|---|---|---|
| HOTAIR (development and morpogenesis) | |||
| GO:0032964 | 0.00e+ 00 | 0.00e+ 00 | collagen biosynthetic process |
| GO:0030199 | 1.72e-14 | 9.36e-12 | collagen fibril organization |
| GO:0030198 | 1.39e-09 | 3.98e-07 | extracellular matrix organization |
| GO:0007275 | 2.07e-07 | 6.27e-05 | multicellular organism development |
| GO:0035115 | 5.31e-07 | 7.63e-05 | embryonic forelimb morphogenesis |
| GO:0060272 | 8.21e-07 | 1.00e-04 | embryonic skeletal joint morphogenesis |
| GO:0048704 | 7.01e-07 | 1.49e-04 | embryonic skeletal system morphogenesis |
| GO:0001568 | 2.13e-06 | 1.88e-04 | blood vessel development |
| GO:0007506 | 7.72e-06 | 1.00e-03 | gonadal mesoderm development |
| GO:0002063 | 1.58e-05 | 1.01e-03 | chondrocyte development |
| HCP5 (immune- and AIDS-related processes) | |||
| GO:0002480 | 0.00e+ 00 | 0.00e+ 00 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent |
| GO:0002504 | 0.00e+ 00 | 0.00e+ 00 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:0002376 | 1.35e-55 | 3.37e-53 | immune system process |
| GO:0050776 | 1.10e-53 | 1.22e-50 | regulation of immune response |
| GO:0006955 | 6.98e-50 | 1.39e-47 | immune response |
| GO:0002250 | 6.06e-28 | 1.35e-25 | adaptive immune response |
| GO:0050852 | 3.56e-27 | 5.93e-25 | T cell receptor signaling pathway |
| GO:0019882 | 7.67e-27 | 1.09e-24 | antigen processing and presentation |
| GO:0045087 | 6.77e-23 | 1.26e-20 | innate immune response |
| GO:0042110 | 8.62e-20 | 1.21e-17 | T cell activation |
| HULC (liver-related processes) | |||
| GO:0002933 | 0.00e+ 00 | 0.00e+ 00 | lipid hydroxylation |
| GO:0006547 | 0.00e+ 00 | 0.00e+ 00 | histidine metabolic process |
| GO:0006572 | 0.00e+ 00 | 0.00e+ 00 | tyrosine catabolic process |
| GO:0010873 | 0.00e+ 00 | 0.00e+ 00 | positive regulation of cholesterol esterification |
| GO:0010898 | 0.00e+ 00 | 0.00e+ 00 | positive regulation of triglyceride catabolic process |
| GO:0016098 | 0.00e+ 00 | 0.00e+ 00 | monoterpenoid metabolic process |
| GO:0030300 | 0.00e+ 00 | 0.00e+ 00 | regulation of intestinal cholesterol absorption |
| GO:0034371 | 0.00e+ 00 | 0.00e+ 00 | chylomicron remodelling |
| GO:0034378 | 0.00e+ 00 | 0.00e+ 00 | chylomicron assembly |
| GO:0042737 | 0.00e+ 00 | 0.00e+ 00 | drug catabolic process |
| H19 (cancer-related processes) | |||
| GO:0007565 | 3.46e-14 | 2.79e-11 | female pregnancy |
| GO:0060397 | 7.14e-08 | 1.92e-05 | JAK-STAT cascade involved in growth hormone signaling pathway |
| GO:0070234 | 1.95e-06 | 3.93e-04 | positive regulation of T cell apoptotic process |
| GO:0007292 | 3.90e-05 | 3.50e-03 | female gamete generation |
| GO:0016486 | 3.90e-05 | 3.50e-03 | peptide hormone processing |
| GO:0030325 | 3.90e-05 | 3.50e-03 | adrenal gland development |
| GO:0007267 | 5.08e-05 | 4.31e-03 | cell-cell signalling |
| GO:0042060 | 8.28e-05 | 5.50e-03 | wound healing |
| GO:0006703 | 1.55e-04 | 8.91e-03 | estrogen biosynthetic process |
| GO:0030540 | 4.66e-04 | 1.75e-02 | female genitalia development |